SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-014581
Filing Date
2020-08-04
Accepted
2020-08-04 14:21:44
Documents
1
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4281
  Complete submission text file 0001493152-20-014581.txt   5715
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Issuer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 126 VALLEY ROAD, SUITE C GLEN ROCK NJ 07452
Business Address
Jones Timothy L. (Reporting) CIK: 0001812101 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 201072709